Chicago Capital Management’s Tourmaline Bio TRML Stock Holding History

Chicago Capital Management’s Portfolio TRML Stock Details TRML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-112,406	Closed	-$5.38M	–	48
2025 Q3	$5.38M	Buy	+112,406	New	+$3.12M	4.81%	8

Chicago Capital Management's TRML Position: Q4 2025 in Review

Chicago Capital Management sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 112,406 shares — an estimated $5.38M sold.

Chicago Capital Management first reported a position in TRML in Q3 2025 and held it in 1 quarter. The position peaked at $5.38M in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

Chicago Capital Management reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
Chicago Capital Management sold 112,406 Tourmaline Bio shares in Q4 2025, an estimated $5.38M.
Chicago Capital Management first reported a position in Tourmaline Bio in Q3 2025 and held it in 1 quarter.
Chicago Capital Management's Tourmaline Bio position peaked at $5.38M in Q3 2025.
0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on Chicago Capital Management's 13F filing for Q4 2025, filed 2 Feb 2026.